SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Pursuant to Section 13 or 15(d) of
The Securities Exchange Act of 1934
Date of Report (Date of earliest event reported)
April 28, 2010
DOLBY LABORATORIES, INC.
(Exact name of registrant as specified in its charter)
(State or other jurisdiction
|(Commission File Number)|| |
100 Potrero Avenue
San Francisco, CA 94103-4813
(Address of principal executive offices) (Zip Code)
(Registrants telephone number, including area code)
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
|¨||Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)|
|¨||Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)|
|¨||Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))|
|¨||Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))|
Section 8 - Other Events
Item 8.01 Other Events.
Dolby Laboratories, Inc. (the Company) announced that the Ray Dolby 2002 Trust A dated April 19, 2002 (Trust A) and the Ray Dolby 2002 Trust B dated April 19, 2002 (Trust B collectively with Trust A, the Trusts) adopted Rule 10b5-1 trading plans in the second quarter of fiscal 2010. Thomas E. Dolby, son of Ray Dolby, holds voting power over shares held by Trust A as Special Trustee of Trust A. David E. Dolby, son of Ray Dolby, holds voting power over shares held by Trust B as Special Trustee of Trust B.
The trading plans were established as part of the Trusts investment strategies for asset diversification and liquidity. The trading plans were adopted during an open window in accordance with guidelines specified by Rule 10b5-1 under the Securities and Exchange Act of 1934, as amended, and as permitted by the Companys insider trading policy.
A total of up to 600,000 shares of the Companys common stock (or approximately 26.0% of Trust As holdings as of April 28, 2010) could be sold under Trust As trading plan. A total of up to 500,000 shares of the Companys common stock (or approximately 21.6% of Trust Bs holdings as of April 28, 2010) could be sold under Trust Bs trading plan. The total of up to 1.1 million shares of the Companys common stock that could be sold under the Trusts trading plans represents approximately 1.8% of Ray Dolbys direct and indirect holdings as of April 28, 2010. Sales under the trading plans may commence in May 2010, are based upon pre-established stock price thresholds, are subject to daily volume limits and will expire once all of the shares have been sold or May 26, 2011, whichever is earlier. Actual sale transactions will be disclosed publicly through filings with the Securities and Exchange Commission as required.
Rule 10b5-1 allows persons who may be considered insiders to adopt pre-arranged written plans for trading specified amounts of stock. A plan establishes predetermined trading parameters that do not permit the person adopting the plan to exercise subsequent influence over how, when or whether to effect trades. Once a plan is set up, trades may be executed at times when the person who adopted the plan is in possession of material nonpublic information, based on the application of the trading parameters determined at the time the plan was adopted. Trading plans are designed to allow persons to sell shares in an orderly fashion for asset diversification, liquidity and tax planning and to avoid concerns about initiating stock transactions while in possession of material, non-public information.
The Company does not undertake any obligation to report Rule 10b5-1 trading plans that may be adopted by any of its officers, directors or stockholders in the future, or to report any modifications or terminations of any publicly announced plan, except to the extent required by law.
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|DOLBY LABORATORIES, INC.|
Murray J. Demo
Chief Financial Officer
Date: April 28, 2010